Mayne Pharma Group Limited FY26 Results Presentation Aaron Gray (CEO) Griffin Buchanan (CFO) 27 August 2026 2 Disclaimer The information provided is general in nature and is in summary form only. It is not complete and should be read in conjunction with the company’s audited Financial...
2026 Full Year Results Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
In the deck
Story so far
Earlier from Mayne Pharma
- 2026 Corporate Governance Statement and Appendix 4G
- Notification of date for release of FY26 results
- Upcoming presentation of Imvexxy clinical data
- Mayne Pharma launches Investor Hub
- Initial Director's Interest Notice
Later from Mayne Pharma
- 2026 Appendix 4E and Annual Report
- 2026 Full Year Results Media Release
- Application for quotation of securities - MYX
- Notification regarding unquoted securities - MYX
- Notification of cessation of securities - MYX
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma
